Instadose Pharma Corp. (INSD)

0.0000 0.0000 (0.00%) At close: 04:34PM EDT

Instadose Pharma Corp.

5500 North Service Road
Suite 301
Burlington, ON L7L 6W6
Canada
905 218 3593
https://www.instadosepharma.com

Sector(s): Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Full-time employees: 

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Grant F. Sanders	Founder & Executive Officer	N/A	N/A	N/A
Mr. Lawrence M. Acton	Chief Operating Officer	N/A	N/A	N/A
Mr. Loren S. Greenspoon J.D., L.L.B.	Chief Legal Officer	N/A	N/A	N/A
Mr. Antonio Rocco Franchino	CEO & Chairman	N/A	N/A	N/A

Amounts are as of 31 December 2021, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Instadose Pharma Corp. engages in growing, cultivation, processing, and global distribution of medical-grade cannabinoid oil. The company was founded in 2017 and is based in Burlington, Canada.

Corporate governance

Instadose Pharma Corp.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.